By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pacific Biosciences today reported fourth-quarter revenues of $12.4 million, beating analysts' consensus estimate of $10.4 million.

The Menlo Park, Calif.-based sequencing technology firm said that it delivered and installed 17 instruments and had six bookings during the quarter ended Dec. 31. As of the end of the year, the company had a backlog of 16 PacBio RS instruments, which represent around $11 million in revenue.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.